EW

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Edwards Lifesciences Corp

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.
CEO
Michael Mussallem
Employees
14900
Headquarters

1 Edwards Way
Irvine, California 92614-5688
Phone: 19492502500
www.edwards.com

News

Edwards Lifesciences cut to equal weight at Wells Fargo on limited upside to TAVR market growth
Mar 08, 2023 15:00pm

https://www.investing.com/news/stock-market-news/edwards-lifesciences-cut-to-equal-weight-at-wells-fargo-on-limited-upside-to-tavr-market-growth-432SI-3025145


Source:Investing.com
Edwards Lifesciences downgraded at Wells Fargo on growth concerns (NYSE:EW)
Mar 08, 2023 13:01pm

Edwards Lifesciences (EW) trended lower in the pre-market Wednesday after Wells Fargo downgraded the MedTech company citing concerns about its topline growth. Read the full story here.


Source:Seeking Alpha
Edwards Lifesciences Corporatio - Consensus Indicates Potential 12.3% Upside - DirectorsTalk Interviews
Mar 08, 2023 11:22am

Edwards Lifesciences Corporatio - Consensus Indicates Potential 12.3% Upside


Source:DirectorsTalk
Wells Fargo Downgrades Edwards Lifesciences to Equal Weight
Mar 08, 2023 10:08am

https://www.investing.com/news/pro/wells-fargo-downgrades-edwards-lifesciences-to-equal-weight-432SI-3024682


Source:Investing.com
Read This First Before You Buy Edwards Lifesciences Corporation (NYSE: EW) Stock
Mar 03, 2023 18:00pm

Edwards Lifesciences Corporation (NYSE:EW) shares, rose in value on Friday, March 03, with the stock price up by 1.36% to the previous day’s close as strong demand from buyers drove the stock to $81.32. Actively observing the price movement in the recent trading, the stock is buoying the session at $80.23, falling within a range … Read This First Before You Buy Edwards Lifesciences Corporation (NYSE: EW) Stock Read More »


Source:Stocks Register
How is EW’s stock performing after recent trades?
Mar 03, 2023 17:40pm

Currently, Edwards Lifesciences Corporation’s (EW) stock is trading at $81.24, marking a gain of 1.26% from last night’s close. At this price, the stock is -38.03% below its 52-week high of $131.10 and 21.02% above its 52-week low of $67.13. Based on the past 30-day period, the stock price is -0.50% below the high and […]


Source:US Post News
Why Edwards Lifesciences Corporation (NYSE: EW) Stock Should Not Be Taken For Granted By Investors In 2023
Feb 28, 2023 19:00pm

In today’s recent session, 1.72 million shares of the Edwards Lifesciences Corporation (NYSE:EW) have been traded, and its beta is 1.02. Most recently the company’s share price was $79.96, and it changed around $2.62 or 3.38% from the last close, which brings the market valuation of the company to $47.87B. EW at last check was … Why Edwards Lifesciences Corporation (NYSE: EW) Stock Should Not Be Taken For Granted By Investors In 2023 Read More »


Source:Marketing Sentinel
CICC Starts Edwards Lifesciences at Outperform
Feb 23, 2023 11:39am

https://www.investing.com/news/pro/cicc-starts-edwards-lifesciences-at-outperform-432SI-3011885


Source:Investing.com
BioLargo Subsidiary Clyra Medical Technologies Adds Two Medical Industry Veterans to its Board of Directors
Feb 20, 2023 13:30pm

WESTMINSTER, CA / ACCESSWIRE / February 20, 2023 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced that its subsidiary Clyra Medical Technologies, Inc. has added two medical industry veterans as new members of its board of directors: Nicholas Valeriani and Linda Park. Nicholas Valeriani has decades of executive experience in the medical device industry. He spent 34 years at Johnson & Johnson, where he led several corporate functions and was a member of its executive committee. Key positions included corporate vice president of human resources, worldwide chairman of medical devices & diagnostics, and Vice President in the Office of Strategy and Growth. He currently serves on the board of directors for Edwards Lifesciences, Surgalign, Inc., SPR Therapeutics, and AgNovos Bioscience. Mr. Valeriani also serves on the board of the Gary and Mary West Health Institute, an independent non-profit medical research organization whose mission is to enable seniors to successfully age in place with access to high quality, affordable healthcare and support services.


Source:Accesswire
Edwards Lifesciences Corporation (NYSE:EW) Shares Dropped -0.26% In A Week. Can It Continue Rising?
Feb 17, 2023 21:00pm

In recent trading session, Edwards Lifesciences Corporation (NYSE:EW) saw 1.07 million shares changing hands at last check today with its beta currently measuring 1.02. Company’s recent per share price level of $77.00 trading at -$0.28 or -0.36% at last check today assigns it a market valuation of $47.83B. That most recent trading price of EW’s … Edwards Lifesciences Corporation (NYSE:EW) Shares Dropped -0.26% In A Week. Can It Continue Rising? Read More »


Source:Marketing Sentinel
Is Edwards Lifesciences Corporation (NYSE: EW) A Stock A New Investor Should Consider Now?
Feb 11, 2023 15:00pm

Edwards Lifesciences Corporation (NYSE:EW) shares, rose in value on Friday, 02/10/23, with the stock price down by -0.10% to the previous day’s close as strong demand from buyers drove the stock to $77.20. Actively observing the price movement in the last trading, the stock closed the session at $77.28, falling within a range of $76.8038 … Is Edwards Lifesciences Corporation (NYSE: EW) A Stock A New Investor Should Consider Now? Read More »


Source:Stocks Register
Enrapturing stocks: Edwards Lifesciences Corporation (NYSE:EW -2.45%), Weyerhaeuser Company (NYSE:WY -0.79%)
Feb 09, 2023 12:15pm

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Enrapturing stocks: Edwards Lifesciences Corporation (NYSE:EW -2.45%), Weyerhaeuser Company (NYSE:WY -0.79%) appeared first on Stocks Equity .


Source:Stock Equity
Edwards Lifesciences Corporation (NYSE: EW) Stock Forecast: Bullish Signals Pointing To $100.00 In 2023
Feb 08, 2023 18:00pm

In today’s recent session, 0.81 million shares of the Edwards Lifesciences Corporation (NYSE:EW) have been traded, and its beta is 1.03. Most recently the company’s share price was $79.36, and it changed around -$0.68 or -0.85% from the last close, which brings the market valuation of the company to $50.93B. EW at last check was … Edwards Lifesciences Corporation (NYSE: EW) Stock Forecast: Bullish Signals Pointing To $100.00 In 2023 Read More »


Source:Marketing Sentinel
Edwards Lifesciences Corporatio - Consensus Indicates Potential 11.9% Upside - DirectorsTalk Interviews
Feb 08, 2023 13:05pm

Edwards Lifesciences Corporatio - Consensus Indicates Potential 11.9% Upside


Source:DirectorsTalk
Edwards Lifesciences downgraded to market perform at Raymond James on growth challenges
Feb 06, 2023 16:15pm

Raymond James has downgraded Edwards Lifesciences (EW) to market perform from outperform due to concerns over slowing growth for transcatheter aortic valve replacements (TAVR).


Source:Seeking Alpha
Raymond James softens on Edwards Lifesciences as confidence in growth profile begins to fade By Investing.com
Feb 06, 2023 15:42pm

Raymond James softens on Edwards Lifesciences as confidence in growth profile begins to fade


Source:Investing.com
Raymond James Downgrades Edwards Lifesciences to Market Perform
Feb 06, 2023 09:05am

https://www.investing.com/news/pro/raymond-james-downgrades-edwards-lifesciences-to-market-perform-432SI-2995779


Source:Investing.com
Edwards Lifesciences Stock: Tremendous Returns Despite High Reinvestments (NYSE:EW)
Feb 05, 2023 08:05am

More recently, Edwards Lifesciences TAVR performance has been volatile. Check out why we would likely look to add to our EW positions if the stock traded down.


Source:Seeking Alpha
Is Edwards Lifesciences Corporation (NYSE:EW) stock a better investment at this time?
Feb 03, 2023 20:24pm

In the current trading session, Edwards Lifesciences Corporation’s (EW) stock is trading at the price of $82.67, a fall of -2.18% over last night’s close. So, the stock is trading at a price that is -36.94% less than its 52-week high of $131.10 and 23.15% better than its 52-week low of $67.13. Based on the […]


Source:US Post News
Edwards Lifesciences Corporation (EW) Q4 2022 Earnings Call Transcript
Feb 02, 2023 10:26am

Edwards Lifesciences Corporation (NYSE:EW) Q4 2022 Earnings Call dated Jan. 31, 2023. Corporate Participants: Mark Wilterding — Senior Vice President, Investor Relations and Treasurer Michael Mussallem — Chairman and Chief Executive Officer Scott Ullem — Corporate […] The post Edwards Lifesciences Corporation (EW) Q4 2022 Earnings Call Transcript first appeared on AlphaStreet .


Source:AlphaStreet
Edwards Lifesciences Corporation (EW) Q4 2022 Earnings Call Transcript | AlphaStreet
Feb 02, 2023 10:26am

Edwards Lifesciences Corporation (NYSE:EW) Q4 2022 Earnings Call dated Jan. 31, 2023.


Source:AlphaStreet
Edwards Lifesciences Awards Secant Group 2022 Supplier of the Year
Feb 01, 2023 19:33pm


Source:Kwhen Finance
CFRA Upgrades Edwards Lifesciences to Buy
Feb 01, 2023 19:21pm

https://www.investing.com/news/pro/cfra-upgrades-edwards-lifesciences-to-buy-432SI-2993515


Source:Investing.com
Wednesday’s Top Analyst Upgrades and Downgrades: Alphabet, Bank of America, Dollar General, Halliburton, Paramount Global, SoFi and More
Feb 01, 2023 13:40pm

Wednesday''s top analyst upgrades and downgrades included Alphabet, Bank of America, Dollar General, Edwards Lifesciences, Fortinet, Fox, Halliburton, LyondellBasell Industries, Paramount Global, SoFi Technologies and Truist Financial.


Source:24/7 Wall street
Edwards Lifesciences Corporatio – Consensus Indicates Potential 18.8% Upside
Feb 01, 2023 11:49am

Edwards Lifesciences Corporatio with ticker code (EW) now have 21 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 128 and 68 with the average target price sitting at 90.38. With the stocks previous close at 76.06 this would imply there is a potential upside of 18.8%. There is a 50 day moving average of 75.69 and the 200 moving average now moves to 89.65. The market cap for the company is $47,421m. Find out more information at: https://www.edwards.com [stock_market_widget type="chart" template="basic" color="green" assets="EW" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $56,349m based on the market concensus. Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases.


Source:DirectorsTalk
Edwards Lifesciences Q4 Earnings Beats Street Estimates, Expects Easing Of Macro Headwinds Later In 2023
Feb 01, 2023 10:34am

Edwards Lifesciences Corp (NYSE: EW ) reported Q4 adjusted EPS of $0.64 , up 25% Y/Y and higher than the consensus of $0.61. The company reported Q4 revenues of $1.35 billion, up 1% and 7% on constant currency, beating the consensus of $1.33 billion. While TAVR sales remained flat year over year, Edwards … Full story available on Benzinga.com


Source:Benzinga
Edwards Lifesciences PT Raised to $84 at Evercore ISI
Feb 01, 2023 08:33am

https://www.investing.com/news/pro/edwards-lifesciences-pt-raised-to-84-at-evercore-isi-432SI-2992782


Source:Investing.com
Edwards Lifesciences Corp (EW) Q4 2022 Earnings Call Transcript
Feb 01, 2023 03:05am

Edwards Lifesciences Corp (NYSE:NYSE:EW) Q4 2022 Earnings Conference Call January 31, 2023 5:00 PM ETCompany ParticipantsMark Wilterding - VP, IRMichael Mussallem - Chairman & CEOScott…


Source:Seeking Alpha
Edwards Lifesciences Corp. Q4 Profit Increases, beats estimates
Jan 31, 2023 21:42pm

WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) revealed earnings for its fourth quarter that increased from the same period last year and beat the Street estimates.The company''s bottom lin…


Source:Finanz Nachrichten
Edwards Lifesciences cut to underperform at Bernstein as organic growth slows
Jan 31, 2023 17:10pm

https://www.investing.com/news/stock-market-news/edwards-lifesciences-cut-to-underperform-at-bernstein-as-organic-growth-slows-432SI-2992379


Source:Investing.com
Edwards Lifesciences Q4 2022 Earnings Preview
Jan 30, 2023 22:35pm

Edwards Lifesciences (EW) is scheduled to announce Q4 earnings results on Tuesday, January 31st, after market close.The consensus EPS Estimate is $0.61 (+19.6% Y/Y) and the…


Source:Seeking Alpha
3 reasons Edwards Lifesciences was downgraded at Piper Sandler today
Jan 30, 2023 19:37pm

https://www.investing.com/news/stock-market-news/3-reasons-edwards-lifesciences-was-downgraded-at-piper-sandler-today-432SI-2991524


Source:Investing.com
Edwards Lifesciences Corporation (NYSE: EW) Continues To Point Downwards
Jan 30, 2023 17:10pm

Edwards Lifesciences Corporation (NYSE:EW) price is hovering lower on Monday, January 30, dropping -2.18% below its previous close. A look at today’s price movement shows that the recent level at last check reads $78.14, with intraday deals fluctuating between $77.81 and $78.84. The company’s 5Y monthly beta was ticking 1.01 while its P/E ratio in … Edwards Lifesciences Corporation (NYSE: EW) Continues To Point Downwards Read More »


Source:Stocks Register
A Preview Of Edwards Lifesciences''s Earnings
Jan 30, 2023 16:01pm

Edwards Lifesciences (NYSE: EW ) is set to give its latest quarterly earnings report on Tuesday, 2023-01-31. Here''s what investors need to know before the announcement. Analysts estimate that Edwards Lifesciences will report an earnings per share (EPS) of $0.61. Edwards Lifesciences bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com


Source:Benzinga
Edwards Lifesciences slips as Piper downgrades on challenging setup
Jan 30, 2023 12:24pm

Edwards Lifesciences (EW) fell more than ~1% pre-market Monday after Piper Sandler downgraded the heart device maker to Neutral from overweight. Read the full story here.


Source:Seeking Alpha
Piper Sandler Downgrades Edwards Lifesciences to Neutral
Jan 30, 2023 08:52am

https://www.investing.com/news/pro/piper-sandler-downgrades-edwards-lifesciences-to-neutral-432SI-2990797


Source:Investing.com